Regulatory & Legal

Amid a $10M loss and a major foreclosure, Bioceres slashes costs and bets on a strategic pivot. Can the ag-tech firm navigate its financial storm?

Medical device firm SI-BONE posts strong Q1 revenue and narrows losses, raising its 2026 outlook on new product momentum and favorable reimbursement news.

Danaos Corp. reports strong Q1 earnings, expanding its fleet with eco-friendly ships and new investments while navigating geopolitical disruptions in key sea lanes.

American Pain Consortium partners with Bluegrass's top pain clinic, reflecting a national trend of private equity investment in specialized healthcare.

Online retailer Haypp Group is back in Alabama, testing a high-stakes model of e-commerce access against the state's tough new age verification laws.

As cheap FPV drones dominate modern battlefields, Axon Vision's new AI-powered ClearSky system offers a high-tech shield for ground troops.

A new government-backed coalition aims to deploy robots across US factories. Can it revitalize manufacturing and navigate the looming workforce challenges?

With key hires from fintech, iGaming, and media, ProphetX is betting big on becoming America's first regulated sports prediction exchange.

By automating the production of a groundbreaking immune therapy, a new collaboration could finally unlock the full potential of personalized medicine for cancer.

Odyssey Marine and AOMC are merging to create a deep-sea mining giant, chasing vital minerals. But can they navigate the immense financial and environmental risks?

United Education Institute's new Houston campus launches with strong government backing, aiming to fill critical skilled trade and healthcare jobs.

With a new CEO, Impossible Metals aims to scale its AI robots for ocean mining. But can its 'green' tech win over fierce environmental opposition?

A new pavilion at France's Hill 70 Memorial honors a forgotten battle and the Franco-Canadian genius who revolutionized modern warfare for the Allies.

After private rejections, Dream Finders Homes takes its acquisition offer public, putting pressure on Beazer's board amid the rival's financial struggles.

As new rules threaten Medicaid for millions, a health coalition released a blueprint for using AI responsibly. But will states and tech vendors listen?

A new drug targeting the root cause of sebum production shows promise in clinical trials, offering hope for millions of moderate to severe acne sufferers.

The Ohio State Bar Association sells its insurer, OBLIC, to national leader ALPS, promising enhanced resources for lawyers in a consolidating market.

A new partnership with SUNY allows national service members to turn their community work into academic credits, lowering college costs and boosting careers.

A new AI from a Nobel laureate-led team claims to predict geopolitical crises. But can we trust a machine with the future of global security?

Dr. Amanda Wilson's appointment to a powerful D.C. council puts her tech-driven addiction treatment model in the national policy spotlight.